Abstract:Yiming Yang, Di Wang, Kaixiong Tao, Guobin Wang Department of Gastrointestinal Surgery, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, 430033, People's Republic of China Correspondence: Guobin Wang, Email Purpose: Colorectal cancer (CRC) is one of the most common carcinomas worldwide with a high mortality rate. Numerous studies suggest that circular RNA (circRNA) plays a crucial role in the progression of various carcinomas, including CRC. The present work focused on exploring the role and underlying molecular mechanism of action of the circRNA circLRCH3 in CRC. Methods: Real-time reverse transcription-quantitative polymerase chain reaction (RT-qPCR) was conducted to detect expression levels of circLRCH3, miR-233, and lipoma preferred partner (LPP). The 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) assay was used to measure the proliferation of CRC cells and the transwell assay was used to evaluate cell migration and invasion capacity. A flow cytometry assay was used to analyze the effect of circLRCH3 on the distribution of the cell cycle and apoptosis of CRC cells. The expression of LPP was analyzed using Western blotting or an RT-qPCR assay. The relationship between miR-223 and circLRCH3, and that between miR-223 and LPP, was predicted and examined using bioinformatics analysis and luciferase reporter gene experiments. A xenograft tumor formation assay was also performed. Results: We found that the expression level of circLRCH3 was downregulated in CRC cells and negatively correlated with miR-223. The overexpression of circLRCH3 or silencing of miR-223 inhibited the growth, invasion, and migration of CRC cells, but promoted their apoptosis. In contrast, overexpression of miR-223 and depletion of LPP severally abrogated the tumor suppressive roles of circLRCH3 and miR-223 knockdown in CRC cells in vitro. The xenograft experiments in nude mice also proved the antitumor effect of circLRCH3. Conclusion: These results suggested that the circLRCH3/miR-223/LPP axis likely plays a critical role in CRC. Keywords: circLRCH3, miR-223, LPP, colorectal cancer, TCGA, GEO Colorectal cancer (CRC) is one of the most prevalent causes of cancer-related morbidity and mortality worldwide. 1–3 Despite numerous therapeutic approaches and novel clinical therapies were employed, the overall survival rate remained poor due to late diagnosis and cancer metastasis. 4,5 Elucidation of the latent developmental mechanism of CRC may enhanced the understanding of the complicated pathogenesis and provide new methods for more effective treatments. Circular RNAs (circRNAs), a group of novel non-coding RNA transcripts characterized by closed continuous loops stably existing in tissues and cells, have been identified in back-splicing precursor mRNA. 6 These circRNAs are characterized by a "head to tail" splicing structure, and dysregulated circRNAs have been reported to play important roles in almost all types of cancers. 7,8 Previous studies have shown that circRNAs play multiple important roles in cellular physiology through their actions as microRNA (miRNA) sponges, RBP-binding molecules, transcriptional regulators, or templates for protein translation. For example, circMRPS35 regulates phosphatase and tensin homolog (PTEN) stability through the circMRPS35-miR-148a-STX3 axis in hepatocellular carcinoma (HCC) cells. 9 Yang et al reported that circ-CTNNB1 promotes β-catenin signaling and cancer progression via DDX3-mediated transactivation of YY1. 10 Gao et al demonstrated that Circular RNA-encoded oncogenic E-cadherin variant promotes glioblastoma development through activation of EGFR–STAT3 signaling. 11 Due to the relatively stable characteristics of circRNA and its important role in the tumorigenicity of CRC, circRNA can serve as a new diagnostic marker and therapeutic target for CRC. MicroRNAs (miRNAs) are a group of endogenous, conserved, noncoding RNAs, typically 18–25 nucleotides long that can regulate numerous biological processes including cell proliferation, migration, differentiation, and apoptosis. 12,13 Furthermore, miRNAs have been shown to decrease the expression of various genes via partial base-pairing to the target mRNA of the target gene 3ʹ untranslated region (3′UTR). 14 Recently, MiR-223 has been demonstrated to be regulated by lncRNA or circRNA via ceRNA crosstalk among diverse cancers. 15,16 However, the regulatory relationship between circRNA and miR-223 has not been reported yet. Lipoma preferred partner (LPP) is a LIM domain protein, which has multiple functions as an actin-binding protein and a transcriptional coactivator, and it has been suggested that LPP has s -Abstract Truncated-

Downregulated long non-coding RNA CLMAT3 promotes the proliferation of colorectal cancer cells by targeting regulators of the cell cycle pathway.

Long non-coding RNA OR3A4 is associated with poor prognosis of human non-small cell lung cancer and regulates cell proliferation via up-regulating SOX4.

LncRNA CCDC144NL-AS1 Serves As a Prognosis Biomarker for Non-small Cell Lung Cancer and Promotes Cellular Function by Targeting Mir-490-3p

Aberrant expression of long noncoding RNAs in colorectal cancer with liver metastasis

MicroRNA-206 Attenuates Tumor Proliferation and Migration Involving the Downregulation of NOTCH3 in Colorectal Cancer.

Long non-coding RNA CCDC144NL-AS1 promotes cell proliferation by regulating the miR-363-3p/GALNT7 axis in colorectal cancer

LINC02595 promotes tumor progression in colorectal cancer by inhibiting miR‐203b‐3p activity and facilitating BCL2L1 expression

miR-144-3p inhibits cell proliferation of colorectal cancer cells by targeting BCL6 via inhibition of Wnt/β-catenin signaling

Suppression of CX3CL1 by miR-497-5p inhibits cell growth and invasion through inactivating the ERK/AKT pathway in NSCLC cells

Downregulation of Wnt3 Suppresses Colorectal Cancer Development Through Inhibiting Cell Proliferation and Migration

Circular RNA circLRCH3 Inhibits Proliferation, Migration, and Invasion of Colorectal Cancer Cells Through miRNA-223/LPP Axis

MiR‐34b‐3p Represses Cell Proliferation, Cell Cycle Progression and Cell Apoptosis in Non‐small‐cell Lung Cancer (NSCLC) by Targeting CDK4

LncRNA LINC00662 promotes colon cancer tumor growth and metastasis by competitively binding with miR-340-5p to regulate CLDN8/IL22 co-expression and activating ERK signaling pathway

LncRNA-cCSC1 promotes cell proliferation of colorectal cancer through sponging miR-124-3p and upregulating CD44

LncCDCA3L Inhibits Cell Proliferation Via a Novel RNA Structure‐based Crosstalk with CDCA3 in Hepatocellular Carcinoma

LncRNA RAD51-AS1/miR-29b/c-3p/NDRG2 crosstalk repressed proliferation, invasion and glycolysis of colorectal cancer

CCL3 Promotes Proliferation of Colorectal Cancer

The Long Non-Coding RNA-RoR Promotes the Tumorigenesis of Human Colorectal Cancer by Targeting miR-6833-3p Through SMC4

Long non-coding RNA MEG3 inhibits NSCLC cells proliferation and induces apoptosis by affecting p53 expression

Downregulation of NCL attenuates tumor formation and growth in HeLa cells by targeting the PI3K / AKT pathway

Claudin-3 Inhibits Lung Squamous Cell Carcinoma Cell Epithelial-mesenchymal Transition and Invasion Via Suppression of the Wnt/β-catenin Signaling Pathway.